CISH (protein)
Cytokine-inducible SH2-containing protein is a protein that in humans is encoded by the CISH gene.[5][6][7] CISH orthologs[8] have been identified in most mammals with sequenced genomes. CISH controls T cell receptor (TCR) signaling, and variations of CISH with certain SNPs are associated with susceptibility to bacteremia, tuberculosis and malaria.[9]
Function
[edit]The protein encoded by this gene contains a SH2 domain and a SOCS box domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling.
The expression of this gene can be induced by IL-2, IL-3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein has been shown to be involved in the inactivation of the erythropoietin receptor.[7]
CISH is induced by T cell receptor (TCR) ligation and negatively regulates it by targeting the critical signaling intermediate PLC-gamma-1 for degradation.[10] The deletion of Cish in effector T cells has been shown to augment TCR signaling and subsequent effector cytokine release, proliferation and survival. The adoptive transfer of tumor-specific effector T cells knocked out or knocked down for CISH resulted in a significant increase in functional avidity and long-term tumor immunity. There are no changes in activity or phosphorylation of Cish's purported target, STAT5 in either the presence or absence of Cish.
In human tumor-infiltrating lymphocytes (TIL), CISH expression has been reported to be inversely expressed with known T cell activation/exhaustion markers and regulates their expression and neoantigen reactivity. Combination therapy with checkpoint blockade synergistically results in profound tumor regressing in a pre-clinical tumor model [11]
Interactions
[edit]CISH has been shown to interact with IL2RB[12] and Growth hormone receptor.[13] and PLCG1.[10]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000114737 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032578 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Uchida K, Yoshimura A, Inazawa J, Yanagisawa K, Osada H, Masuda A, et al. (Mar 1998). "Molecular cloning of CISH, chromosome assignment to 3p21.3, and analysis of expression in fetal and adult tissues". Cytogenetics and Cell Genetics. 78 (3–4): 209–212. doi:10.1159/000134658. PMID 9465889.
- ^ Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, et al. (June 1995). "A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors". The EMBO Journal. 14 (12): 2816–2826. doi:10.1002/j.1460-2075.1995.tb07281.x. PMC 398400. PMID 7796808.
- ^ a b "Entrez Gene: CISH cytokine inducible SH2-containing protein".
- ^ "OrthoMaM phylogenetic marker: CISH coding sequence". Archived from the original on 2016-03-04. Retrieved 2010-02-17.
- ^ Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, et al. (June 2010). "CISH and susceptibility to infectious diseases". The New England Journal of Medicine. 362 (22): 2092–2101. doi:10.1056/NEJMoa0905606. PMC 3646238. PMID 20484391.
- ^ a b Palmer DC, Guittard GC, Franco Z, Crompton JG, Eil RL, Patel SJ, et al. (November 2015). "Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance". The Journal of Experimental Medicine. 212 (12): 2095–2113. doi:10.1084/jem.20150304. PMC 4647263. PMID 26527801.
- ^ Palmer DC, Webber BR, Patel Y, Johnson MJ, Kariya CM, Lahr WS, et al. (2022). "Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade". Med. 3 (10): 682–704.e8. doi:10.1016/j.medj.2022.07.008. PMC 9847506. PMID 36007524.
{{cite journal}}: CS1 maint: overridden setting (link) - ^ Aman MJ, Migone TS, Sasaki A, Ascherman DP, Zhu M, Soldaini E, et al. (October 1999). "CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling". The Journal of Biological Chemistry. 274 (42): 30266–30272. doi:10.1074/jbc.274.42.30266. PMID 10514520.
- ^ Ram PA, Waxman DJ (December 1999). "SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms". The Journal of Biological Chemistry. 274 (50): 35553–35561. doi:10.1074/jbc.274.50.35553. PMID 10585430.
Further reading
[edit]- Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ (May 2002). "The SOCS box: a tale of destruction and degradation". Trends in Biochemical Sciences. 27 (5): 235–241. doi:10.1016/S0968-0004(02)02085-6. PMID 12076535.
- Verdier F, Chrétien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, et al. (October 1998). "Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein". The Journal of Biological Chemistry. 273 (43): 28185–28190. doi:10.1074/jbc.273.43.28185. PMID 9774439.
- Okabe S, Tauchi T, Morita H, Ohashi H, Yoshimura A, Ohyashiki K (October 1999). "Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway". Experimental Hematology. 27 (10): 1542–1547. doi:10.1016/S0301-472X(99)00094-6. PMID 10517496.
- Jiang C, Yu L, Zhao Y, Zhang M, Liu Q, Mao N, et al. (2000). "Cloning and characterization of CIS 1b (cytokine inducible SH2-containing protein 1b), an alternative splicing form of CIS 1 gene". DNA Sequence. 11 (1–2): 149–154. doi:10.3109/10425170009033983. PMID 10902923. S2CID 7986394.
- Dogusan Z, Hooghe-Peters EL, Berus D, Velkeniers B, Hooghe R (September 2000). "Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines". Journal of Neuroimmunology. 109 (1): 34–39. doi:10.1016/S0165-5728(00)00300-3. PMID 10969179. S2CID 23752435.
- Yousefi S, Cooper PR, Mueck B, Potter SL, Jarai G (October 2000). "cDNA representational difference analysis of human neutrophils stimulated by GM-CSF". Biochemical and Biophysical Research Communications. 277 (2): 401–409. doi:10.1006/bbrc.2000.3678. PMID 11032736.
- Dif F, Saunier E, Demeneix B, Kelly PA, Edery M (December 2001). "Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor". Endocrinology. 142 (12): 5286–5293. doi:10.1210/endo.142.12.8549. PMID 11713228.
- Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C (July 2002). "Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1". Journal of Immunology. 169 (1): 434–442. doi:10.4049/jimmunol.169.1.434. PMID 12077274.
- Du L, Frick GP, Tai LR, Yoshimura A, Goodman HM (March 2003). "Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes". Endocrinology. 144 (3): 868–876. doi:10.1210/en.2002-220830. PMID 12586763.
- Chen S, Anderson PO, Li L, Sjögren HO, Wang P, Li SL (March 2003). "Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells". International Immunology. 15 (3): 403–409. doi:10.1093/intimm/dxg039. PMID 12618484.
- Yamasaki K, Hanakawa Y, Tokumaru S, Shirakata Y, Sayama K, Hanada T, et al. (April 2003). "Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes". The Journal of Investigative Dermatology. 120 (4): 571–580. doi:10.1046/j.1523-1747.2003.12100.x. hdl:11094/44640. PMID 12648219.
- Cheng J, Zhang D, Zhou C, Marasco WA (January 2004). "Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells". Leukemia Research. 28 (1): 71–82. doi:10.1016/S0145-2126(03)00158-9. PMID 14630083.
- Bayle J, Letard S, Frank R, Dubreuil P, De Sepulveda P (March 2004). "Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling". The Journal of Biological Chemistry. 279 (13): 12249–12259. doi:10.1074/jbc.M313381200. PMID 14707129.
- Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, et al. (July 2004). "Functional proteomics mapping of a human signaling pathway". Genome Research. 14 (7): 1324–1332. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
- Hunter MG, Jacob A, O'donnell LC, Agler A, Druhan LJ, Coggeshall KM, et al. (October 2004). "Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia". Journal of Immunology. 173 (8): 5036–5045. doi:10.4049/jimmunol.173.8.5036. PMID 15470047.
External links
[edit]- Human CISH genome location and CISH gene details page in the UCSC Genome Browser.